Tailored Treatment in Metastatic Colorectal Cancer

Sponsor
Vejle Hospital
Study ID
NCT00396487
Phase
PHASE3
Status
Terminated

Conditions

  • Metastatic Colorectal Cancer

Eligibility Criteria

Sex
ALL
Age
60 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

To compare the response rate of single agent chemotherapy in advanced colorectal cancer given as standard treatment versus tailored treatment in a randomised phase III trial.

Key Dates

Start date
Nov 30, 2006
Status verified
Jun 2015
Completion
Feb 29, 2008

Study Design

Enrollment
1 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Primary Outcome Measure

The primary end point is

Related Studies